Skip to content
★ Sign in to follow
JP

Jerusalem Pharmaceuticals Stock: price and insider trades · Palestine

1 insider bought shares over the last 90 days, the latest by محمد محمود يوسف مسروجي, filed 14 Oct 2026.

Insider Decl.
29
Thresholds
n/a
Buy Volume
n/a
28 ops. · all time
Sell Volume
n/a
1 ops. · all time

Jerusalem Pharmaceuticals: what insiders have been doing

Jerusalem Pharmaceuticals is a listed company. Its insiders report their share dealings to PCMA / Palestine Exchange. From 15 November 2025 to 15 November 2026, the disclosure feed for Jerusalem Pharmaceuticals logged 11 filings by 4 insiders.

Only purchases show up on the open market, 11 purchases in all, filed by 4 insiders. No amount is published for 11 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 2 board members, 1 senior executive and 1 chief executive.

For context, the typical company on the same exchange (median of 51 companies) published 9 filings over the same period, against 11 filings here. Since 2018, the database holds 28 purchases and 1 sale by insiders of the company.

The most recent open-market purchase was published on 14 October 2026, 34 days ago.

This summary is built from PCMA / Palestine Exchange disclosures alone and does not predict where the share price will go.

Who traded when

BuySale
ابراهيم علي سليمان طويل6 buys
محمد محمود يوسف مسروجي4 buys
اياد محمد محمود مسروجي1 sale
رامي وليد محمد قطب1 buy
محمد فاروق يوسف الناطور1 buy

Financial data

· cache

Last declaration on 14 October 2026

T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.

Declarations29 total

25 of 29 declarations

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals is a company engaged in the manufacturing and distribution of pharmaceutical products. It operates in the XPAE market.

Written on 14 November 2026 from the filings and market data available that day. Live figures are in the blocks above.

The weekly insider digest, free

One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.